Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > Cash from Financing Activities

Amag Pharmaceuticals Cash from Financing Activities Chart (AMAG)

Amag Pharmaceuticals annual/quarterly Cash from Financing Activities from 2010 to 2020.
  • Amag Pharmaceuticals Cash from Financing Activities for the quarter ending June 06, 2020 was $1m a 117.86% increase of 1m year over year
  • Amag Pharmaceuticals Cash from Financing Activities for the last 12 months ending June 06, 2020 was $0m a -18,904.89% increase of 35m year over year
  • Amag Pharmaceuticals Annual Cash from Financing Activities for 2019 was $-36m a -1,313.49% increase of 466m from 2018
  • Amag Pharmaceuticals Annual Cash from Financing Activities for 2018 was $-502m a 41.50% decrease of -208m from 2017
  • Amag Pharmaceuticals Annual Cash from Financing Activities for 2017 was $-294m a 56.44% decrease of -166m from 2016
Other Cash Flow Metrics:
  • Amag Pharmaceuticals Cash Flow from Operations for the quarter ending December 12, 2018 was $-34m a 162.36% decrease of -55m year over year
  • Amag Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-31m a 66.13% decrease of -21m year over year
  • Amag Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $122m a -29.53% decrease of -36m year over year
View Chart On Koyfin

Quarterly AMAG Cash from Financing Activities Data

06/2020$1m
03/2020$-1m
12/2019$1m
09/2019$0m
06/2019$1m
03/2019$-37m
12/2018$1m
09/2018$-502m
03/2018$-2m
12/2017$-84m

Annual AMAG Cash from Financing Activities Data

2019$-36m
2018$-502m
2017$-294m
2016$-128m
2015$912m
2014$514m
2013$1m
2012$0m
2011$1m
2010$168m